Related Experiment Videos
The molecular mechanisms of dopamine toxicity
Ari Barzilai1, Dorah Daily, Rina Zilkha-Falb
1Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Advances in Neurology
|November 22, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neurofilament Light Chain Measurements by Centaur and Simoa Systems in Human and Murine Samples.
The Israel Medical Association journal : IMAJ·2026
Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side Effects.
International journal of molecular sciences·2025
Mesenchymal stem cell-derived exosomes mitigate amyloid β-induced retinal toxicity: Insights from rat model and cellular studies.
Journal of extracellular biology·2025
Machine learning-based prediction of disease progression in primary progressive multiple sclerosis.
Brain communications·2025
Efficacy of therapy by MK-28 PERK activation in the Huntington's disease R6/2 mouse model.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2024
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Evaluating Combined Sorafenib and Gemcitabine Treatment in HepG2 Cells and a NOD/SCID Mouse Xenograft Model: A Pilot Study.
Journal of visualized experiments : JoVE·2026
An Engineering-Editable Hybrid Membrane‑Camouflaged DNA Origami Drug Enables Checkpoint Blockade and Immune Activation for Triple-Negative Breast Cancer Immunotherapy.
Angewandte Chemie (International ed. in English)·2026
Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Restoration of m6A-Modified circPSMB1 Suppresses Chordoma Progression and Enables Local Nanotherapeutic Intervention.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026